Earlens Image

Earlens Corporation

Premium Non-Surgical Hearing Lens Solution

Raised $15,000,000

Convertible Notes

  • About 28.8 million U.S. adults have reduced hearing ability – traditional hearing aid technology is inadequate, delivering less than 40% of the full audible range.

  • Earlens has created and now offers to its patients a revolutionary hearing “lens“ that gently vibrates the eardrum directly, thus providing each user substantially improved hearing experience with 2.5x the audible bandwidth of conventional hearing aids. Video: 9/22/2021 NBC TV Coverage

  • Based upon clinical data, patients who wear Earlens:

    • Experience a statistically significant improvement in hearing,
    • Prefer the hearing experience of Earlens 8:1 over conventional hearing aids,
    • Experience 16x closer to normal hearing in critical high frequencies,
    • Perform better in significantly noisier situations,
    • Receive a more natural listening experience with a more natural sound quality, and benefit from 32% better speech recognition (vs. conventional hearing aids).
  • 73% of recent Earlens patients have switched from their traditional hearing aids. 3,000+ Earlens have been placed to date.

  • Earlens sales are made in partnership with ENT physicians (ear, nose, and throat) and audiologists who also provide ongoing patient support – the “Earlens Concierge” service.

  • President & CEO William (Bill) Facteau, a 30-year veteran of the healthcare technology industry, and senior management have a successful track record delivering break-through technologies to over 3,500 ENT physicians.

Earlens Corporation (the “Issuer” or the "Company”) issued $15,000,000 in convertible notes (the “Notes”) to fund further commercialization and product development.

By registering with Carofin, Members have access to more extensive due diligence materials, additional private investment opportunities, and can proceed with making an investment.